C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2001
11/27/2001	US6322792 Gamma-2 herpes viruses like kaposi's sarcoma-associated herpes virus useful in modulating persistence of heterologous dna; gene therapy
11/27/2001	US6322727 Kit for conducting an assay to detect a substance using enzymatically-induced decomposition of dioxetanes
11/27/2001	CA2244790C Method for evaluating drug metabolism and reagent compositions therefor
11/27/2001	CA2178004C Indicator cell line for detecting rna viruses and method therefor
11/27/2001	CA2145866C Human calcitonin receptor
11/26/2001	CA2308260A1 Blocking cell-division as a therapeutic treatment of pathogenic bacteria
11/22/2001	WO2001088545A1 Il-6 detection for predicting risks of preterm delivery
11/22/2001	WO2001088544A2 Proteolytic enzymes in diagnosis of kidney disorders
11/22/2001	WO2001088543A2 Methods and compositions for diagnosing chronic immune disease
11/22/2001	WO2001088533A2 Lipid uptake assays
11/22/2001	WO2001088532A2 Improved assay techniques using nematode worms
11/22/2001	WO2001088531A1 Method for detection of biological related materials using biomarkers
11/22/2001	WO2001088526A1 Biosensor and method for manufacturing the same
11/22/2001	WO2001088518A2 Microelectrogravimetric method for plating a biosensor
11/22/2001	WO2001088511A1 Grating optical waveguide structure for multi-analyte determinations and the use thereof
11/22/2001	WO2001088203A1 Cloning of rhadinovirus genome and methods for its use
11/22/2001	WO2001088202A1 Haplotypes of the pon2 gene
11/22/2001	WO2001088201A1 Haplotypes of the rras gene
11/22/2001	WO2001088200A2 Isolation of genes within sle-1b taht mediate a beak in immune tolerance
11/22/2001	WO2001088199A2 Identification and modulationof of a t helper-1 and t helper-2 cells
11/22/2001	WO2001088197A2 Methods and compositions for interaction trap assays
11/22/2001	WO2001088196A2 Sequence based screening
11/22/2001	WO2001088195A1 Detection of nucleic acid hybridization by fluorescence polarization
11/22/2001	WO2001088194A1 Methods and compositions for amplifying intracellular signal transduction
11/22/2001	WO2001088193A2 Follicle stimulating hormone stimulated genes and uses thereof
11/22/2001	WO2001088190A2 Poly-primed amplification of nucleic acid sequences
11/22/2001	WO2001088189A2 Microsatellite-aflp®
11/22/2001	WO2001088188A2 Method for examining ischemic conditions
11/22/2001	WO2001088186A2 Methods for detecting and identifying a gram positive bacteria in a sample
11/22/2001	WO2001088185A2 A filter element for use in separation of biomaterials from solid contaminants
11/22/2001	WO2001088184A2 Compositions and methods for genetic analyses
11/22/2001	WO2001088183A2 Method for the isolation of helicobacter pylori
11/22/2001	WO2001088181A1 Methods for detecting for the presence of tumor cells and for screening for anti-tumor agents
11/22/2001	WO2001088178A2 Peptide substrates for direct measuring of enzyme activities
11/22/2001	WO2001088177A2 Stain solution, which is devoid of phenol, for bacteria
11/22/2001	WO2001088176A2 Measurements of enzymatic activity in a single, individual cell in population
11/22/2001	WO2001088174A1 Novel compositions and methods for carrying out multiple pcr reactions on a single sample
11/22/2001	WO2001088148A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/22/2001	WO2001088136A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/22/2001	WO2001088131A1 Regulation of mt1-mmp activity
11/22/2001	WO2001088128A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/22/2001	WO2001088126A2 REGULATION OF HUMAN α1Α ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR
11/22/2001	WO2001088125A1 MUTATION IN THE β2 NICOTINIC ACETYLCHOLINE RECEPTOR SUBUNIT ASSOCIATED WITH NOCTURNAL FRONTAL LOBE EPILEPSY
11/22/2001	WO2001088120A1 Gene associating open-angle glaucoma including normal ocular tension glaucoma
11/22/2001	WO2001088118A1 Novel motor proteins and methods for their use
11/22/2001	WO2001088116A2 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods
11/22/2001	WO2001088108A1 Neuronal serine-threonine protein kinase
11/22/2001	WO2001088104A2 Neural progenitor cell populations
11/22/2001	WO2001088103A2 Compositions and methods for tissue dedifferentiation and regeneration
11/22/2001	WO2001088101A2 CELL LINE FOR THE EXPRESSION OF AN α2δ2 CALCIUM CHANNEL SUBUNIT
11/22/2001	WO2001088097A1 Immune potentiating compositions
11/22/2001	WO2001088089A2 Single copy genomic hybridization probes and method of generating same
11/22/2001	WO2001088087A2 Microfluidic channel embryo and/or oocyte handling, analysis and biological evaluation
11/22/2001	WO2001087980A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
11/22/2001	WO2001087938A2 Polynucleotide sequence encoding a putative cell adhesion molecule
11/22/2001	WO2001087937A2 G-protein coupled receptors
11/22/2001	WO2001087935A2 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg)
11/22/2001	WO2001087923A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors
11/22/2001	WO2001087921A2 Gene responsible for stargardt-like dominant macular dystrophy
11/22/2001	WO2001087910A2 Haplotypes of the gnrh2 gene
11/22/2001	WO2001087909A2 Haplotypes of the aanat gene
11/22/2001	WO2001087908A2 Haplotypes of the ccr3 gene
11/22/2001	WO2001087907A2 Haplotypes of the osm gene
11/22/2001	WO2001087906A2 Haplotypes of the stk11 gene
11/22/2001	WO2001087905A2 Haplotypes of the adora2a gene
11/22/2001	WO2001087904A2 Haplotypes of the gpr4 gene
11/22/2001	WO2001087903A2 Haplotypes of the acaa1 gene
11/22/2001	WO2001087768A2 Use of vapor-deposited conformal coatings in microfluidic structures
11/22/2001	WO2001087352A1 Reverse isotope dilution assay and lactose intolerance assay
11/22/2001	WO2001087351A1 Method for treatment of tumors using nucleic acid ligands to pdgf
11/22/2001	WO2001087350A2 Treatment of human papillomavirus (hpv)-infected cells
11/22/2001	WO2001087338A1 Immunomodulatory human mhc class ii antigen-binding polypeptides
11/22/2001	WO2001087337A1 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
11/22/2001	WO2001087330A2 Compositions and methods for achieving immune suppression
11/22/2001	WO2001087300A1 Creatinine biosensor
11/22/2001	WO2001087231A2 Methods and compositions for the diagnosis of schizophrenia
11/22/2001	WO2001087039A2 Treatment of neoplasia / transformation using pituitary tumor transforming gene 2
11/22/2001	WO2001055333A8 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides
11/22/2001	WO2001036977A3 Identification of disease markers involving mass-based-separation
11/22/2001	WO2001036679A3 METHODS FOR GENERATING SINGLE STRANDED cDNA FRAGMENTS
11/22/2001	WO2001036639A3 Bt toxin receptors from lepidopteran insects and methods of use
11/22/2001	WO2001036476A3 Ing2, an iaps associated cell cycle protein, compositions and methods of use
11/22/2001	WO2001036463A3 Genes specifically expressed in human dendritic cells
11/22/2001	WO2001034805A3 Human vanilloid receptor gene
11/22/2001	WO2001032891A3 Human lipase
11/22/2001	WO2001032845A3 Methods for the preparation of (lipo)peptide synthetases and (lipo)peptides produced therewith
11/22/2001	WO2001031059A8 Genetic biosensors using chemiluminescence
11/22/2001	WO2001030986A3 Human pif1 dna helicase and uses thereof
11/22/2001	WO2001030969A8 Stanniocalcin proteins and nucleic acids and methods based thereon
11/22/2001	WO2001027269A3 Vip54 protein and related materials
11/22/2001	WO2001027146A3 Chemokine receptor
11/22/2001	WO2001020042A3 Method for processing biological samples
11/22/2001	WO2001019380A3 Oncolytic virus
11/22/2001	WO2001018548A3 Protecting alkylating reagents used for quantifying homocysteine
11/22/2001	WO2001018254A3 Mutant of rad51 gene and its use in the diagnosis of predisposition to breast cancer
11/22/2001	WO2001014564A3 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby
11/22/2001	WO2000070089A9 Cdx2 is downstream mediator of apc tumor suppressor activity
11/22/2001	WO2000055633A9 Methods of screening for colorectal cancer modulators
11/22/2001	US20010044936 Identification of mutants after splicing with intronic primers; transgenic model systems
11/22/2001	US20010044699 Predicting metabolic stability of drug molecules

1 ... 2376 2377 2378 2379 2380 2381 2382 2383 2384 2385 2386 2387 2388 2389 2390 2391 2392 2393 2394 2395 2396 ... 3003